PMC:7361216 / 4423-4937
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T56 | 32-35 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T57 | 104-107 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T58 | 108-116 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T59 | 151-156 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T60 | 224-227 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T61 | 238-246 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T62 | 414-417 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T12 | 36-57 | Disease | denotes | monoclonal gammopathy | http://purl.obolibrary.org/obo/MONDO_0004960 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T65 | 149-156 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cells |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T37 | 377-384 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
| T38 | 471-478 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T17 | 151-156 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
| T18 | 195-202 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
| T19 | 403-413 | http://purl.obolibrary.org/obo/IDO_0000450 | denotes | pathogenic |
| T20 | 426-433 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T32 | 352-357 | Chemical | denotes | PPSGG | http://purl.obolibrary.org/obo/CHEBI_137080 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T27 | 0-172 | Sentence | denotes | In patients suffering from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituximab. |
| T28 | 173-324 | Sentence | denotes | On occasion flares of disease occur with increased IgM levels of antibody targeting MAG have followed therapy with Rituximab (Broglio and Luria, 2005). |
| T29 | 325-434 | Sentence | denotes | The strategy employed with PPSGG is specific to the antigen that triggers the pathogenic IgM in this disease. |
| T30 | 435-514 | Sentence | denotes | One can refer to such treatment as “antigen‐specific” immunotherapy (Figure 1). |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 122 | 3-11 | Species | denotes | patients | Tax:9606 |
| 123 | 162-171 | Chemical | denotes | Rituximab | MESH:D000069283 |
| 121 | 257-260 | Gene | denotes | MAG | Gene:4099 |
| 124 | 288-297 | Chemical | denotes | Rituximab | MESH:D000069283 |
| 125 | 352-357 | Chemical | denotes | PPSGG |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T50 | 144-148 | Protein | denotes | CD20 | https://www.uniprot.org/uniprot/Q3C2E2|https://www.uniprot.org/uniprot/Q13963|https://www.uniprot.org/uniprot/P19437|https://www.uniprot.org/uniprot/P11836|https://www.uniprot.org/uniprot/P08984|https://www.uniprot.org/uniprot/B4DT24|https://www.uniprot.org/uniprot/A6NMS4 |
| T57 | 257-260 | Protein | denotes | MAG | https://www.uniprot.org/uniprot/Q567S4 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T56 | 32-35 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T57 | 104-107 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T58 | 108-116 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T59 | 151-156 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T60 | 224-227 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T61 | 238-246 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T62 | 414-417 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T15 | 36-57 | Disease | denotes | monoclonal gammopathy | http://purl.obolibrary.org/obo/MONDO_0004960 |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T5 | 214-234 | Phenotype | denotes | increased IgM levels | http://purl.obolibrary.org/obo/HP_0003496 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T5 | 214-234 | Phenotype | denotes | increased IgM levels | http://purl.obolibrary.org/obo/HP_0003496 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T27 | 0-172 | Sentence | denotes | In patients suffering from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituximab. |
| T28 | 173-324 | Sentence | denotes | On occasion flares of disease occur with increased IgM levels of antibody targeting MAG have followed therapy with Rituximab (Broglio and Luria, 2005). |
| T29 | 325-434 | Sentence | denotes | The strategy employed with PPSGG is specific to the antigen that triggers the pathogenic IgM in this disease. |
| T30 | 435-514 | Sentence | denotes | One can refer to such treatment as “antigen‐specific” immunotherapy (Figure 1). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 121 | 257-260 | Gene | denotes | MAG | Gene:4099 |
| 122 | 3-11 | Species | denotes | patients | Tax:9606 |
| 123 | 162-171 | Chemical | denotes | Rituximab | MESH:D000069283 |
| 124 | 288-297 | Chemical | denotes | Rituximab | MESH:D000069283 |
| 125 | 352-357 | Chemical | denotes | PPSGG |